Mai Capital Management Biolife Solutions Inc Transaction History
Mai Capital Management
- $15.6 Billion
- Q3 2025
A detailed history of Mai Capital Management transactions in Biolife Solutions Inc stock. As of the latest transaction made, Mai Capital Management holds 69 shares of BLFS stock, worth $1,660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69Holding current value
$1,660% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BLFS
# of Institutions
206Shares Held
47.6MCall Options Held
12.6KPut Options Held
0-
Casdin Capital, LLC New York, NY6.71MShares$161 Million23.32% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$132 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.07MShares$97.9 Million0.06% of portfolio
-
Invesco Ltd. Atlanta, GA3.6MShares$86.6 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.97MShares$71.4 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.03B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...